Evidence map›Paper›PMID 30012569›Full record

ArticleRNA (New York, N.Y.)2018

Guillaume Beauclair, Marie Mura, Chantal Combredet, Frédéric Tangy, Nolwenn Jouvenet, Anastassia V Komarova

Abstract read
In one paragraph

Article in RNA (New York, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guillaume BeauclairUnité de Génomique Virale et Vaccination, Institut Pasteur, Paris, 75015, France.ORCID 0000-0001-5323-5987
Marie MuraUnité de Génomique Virale et Vaccination, Institut Pasteur, Paris, 75015, France.
Chantal CombredetUnité de Génomique Virale et Vaccination, Institut Pasteur, Paris, 75015, France.
Frédéric TangyUnité de Génomique Virale et Vaccination, Institut Pasteur, Paris, 75015, France.ORCID 0000-0002-5937-5654
Nolwenn JouvenetUnité de Génomique Virale et Vaccination, Institut Pasteur, Paris, 75015, France.ORCID 0000-0001-6103-6048
Anastassia V KomarovaUnité de Génomique Virale et Vaccination, Institut Pasteur, Paris, 75015, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Defective interfering (DI) genomes, or defective viral genomes (DVGs), are truncated viral genomes generated during replication of most viruses, including live viral vaccines. Among these, "panhandle" or copy-back (cb) and "hairpin" or snap-back (sb) DI genomes are generated during RNA virus replication. 5' cb/sb DI genomes are highly relevant for viral pathogenesis since they harbor immunostimulatory properties that increase virus recognition by the innate immune system of the host. We have developed

Indexed as

Genome, ViralGenomicsSoftwareCell LineComputational BiologyDefective VirusesGenes, rRNAHigh-Throughput Nucleotide SequencingHumansReproducibility of ResultsRNA, ViralSensitivity and SpecificityVirus ReplicationRNA, Viralcopy-backdefective interfering viral genomeNGSpanhandlesnap-backviral replication

Identifiers

PMID30012569
PMCPMC6140465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.